Keywords: Targeted receptor TKIs; Acquired resistance to receptor TKIs; Overcoming drug resistance; Driver oncogenes; Gate keeper receptor mutations; Bypass signaling molecules; ABC; ATP-binding cassette; AKT/PKB; Protein kinase B; ALK; Anaplastic lymphoma kinase;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Bioanalytical assay for the quantification of the ALK inhibitor lorlatinib in mouse plasma using liquid chromatography-tandem mass spectrometry
Keywords: ALK; anaplastic lymphoma kinase; EMA; European Medicines Agency; EML4; echinoderm microtubule-associated protein-like 4; ESI; electro spray ionization; FDA; Food and Drug Administration; IS; internal standard; LC-MS/MS; liquid chromatography-tandem mass s
Scaffold hopping identifies 6,8-disubstituted purines as novel anaplastic lymphoma kinase inhibitors
Keywords: ALK; anaplastic lymphoma kinase; cMet; hepatocyte growth factor receptor; DIPEA; N,N-Diisopropylethylamine; DMF; N,N-Dimethylformamide; EML4; echinoderm microtubule-associated protein-like 4; FDA; food and drug administration; gk; gatekeeper; μW; micro w
Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review
Keywords: Concomitant; Echinoderm microtubule-associated protein-like 4; Epidermal growth factor receptor; NSCLC; Tyrosine kinase inhibitor;
HIP1-ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Keywords: Huntingtin interacting protein 1; anaplastic lymphoma kinase; HIP1-ALK; Echinoderm microtubule-associated protein-like 4; EML4-ALK; Non-small-cell lung cancer; Crizotinib (PF-02341066); Patient-derived xenograft (PDX) tumor model;
Personalized Oncology in Interventional Radiology
Keywords: ATP; adenosine triphosphate; ALK; analplastic lymphoma factor; BCR-ABL; breakpoint cluster region/the Abelson tyrosine; BRAF; v-raf murine sarcoma viral oncogene; CD-20; clusters of differentiation-20 (antigen of B-cells); c-KIT; tyrosine-protein kinase k